Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis
Clinical trial NCT03180723 · UNKNOWN
Trial details
- NCT number
- NCT03180723
- Sponsor
- Assiut University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.